Originally believed to be primarily a disease of postmenopausal women with or without autoimmune disorders, it is now recognized that dry eye disease (DED) affects patients of both sexes at younger ages.
Dry Eye Disease
A new therapy is being investigated in a phase IIb trial to test its safety and effectiveness in patients with moderate-to-severe dry eye disease.
Editor’s Note: Welcome to “Let's Chat,” a blog series featuring contributions from members of the ophthalmic community.
In our latest episode, Laura M. Periman, MD, shares her experience using intense pulsed light (IPL) therapy, and the benefits she's found in it for treating patients with chalazion.
Supplementation no better than placebo as results confirm previous research
Harvey A. Fishman, MD, PhD, shares why intense pulsed light (IPL) therapy is a valuable asset in any ophthalmologist's toolbox
Poor eyelid performance while sleeping a common contributing factor